Clinical Trial Results: Nasopharyngeal Cancer

Home

Results

Protocol Registry

Trial Results

IFPMA

Background

Links

About this Registry

This database is populated with information on the results of Roche-sponsored clinical trials.

What are the differences between clinical trial phases?

Why has Roche decided to have its own registry and results database?

More FAQs

Glossary of Terms

Phase Definitions

Field Definitions

Clinical Trial Policy

Site Provided by Thomson CenterWatch

Clinical Trial Results: Nasopharyngeal Cancer

Product Name: Xeloda [capecitabine]
Date of Report: To be Published
Phase: II
A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Metastatic Nasopharyngeal Cancer

Product Name: Xeloda [capecitabine]
Date of Report: To be Published
Phase: II
A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients WIth Metastatic Nasopharyngeal Cancer.


© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement

Home

Trial Results updated: August 19, 2008 at 4:49:48 PM